| Pharmaceutical Information |
| Drug Name |
Bromazepam |
| Drug ID |
BADD_D00299 |
| Description |
One of the benzodiazepines that is used in the treatment of anxiety disorders. It is a Schedule IV drug in the U.S. and Canada and under the Convention on Psychotropic Substances. It is a intermediate-acting benzodiazepine. |
| Indications and Usage |
For the short-term treatment of insomnia, short-term treatment of anxiety or panic attacks, if a benzodiazepine is required, and the alleviation of the symptoms of alcohol- and opiate-withdrawal. |
| Marketing Status |
Not Available |
| ATC Code |
N05BA08 |
| DrugBank ID |
DB01558
|
| KEGG ID |
D01245
|
| MeSH ID |
D001960
|
| PubChem ID |
2441
|
| TTD Drug ID |
D0E3FD
|
| NDC Product Code |
Not Available |
| Synonyms |
Bromazepam | Apo-Bromazepam | Apo Bromazepam | BromaLich | Bromaz 1A Pharma | Bromazanil | Bromazep Von Ct | Von Ct, Bromazep | Bromazepam AL | Bromazepam Beta | Beta, Bromazepam | Bromazepam Heumann | Bromazepam-Neuraxpharm | Bromazepam Neuraxpharm | Bromazepam-Ratiopharm | Bromazepam Ratiopharm | Durazanil | Gen-Bromazepam | Gen Bromazepam | Lexotan | Lexomil | Lexatin | Lexotanil | Ro 5-3350 | Ro 53350 | Anxyrex |
|
| Chemical Information |
| Molecular Formula |
C14H10BrN3O |
| CAS Registry Number |
1812-30-2 |
| SMILES |
C1C(=O)NC2=C(C=C(C=C2)Br)C(=N1)C3=CC=CC=N3 |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
